USD10
FDMT Ações
Sobre 4D Molecular Therapeutics4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
USD10
FDMT Ações
Sobre 4D Molecular Therapeutics4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Estatísticas
JANELA DE NEGOCIAÇÃO
Fechado
ABRE ÀS
Sem dados suficientes
CAPITALIZAÇÃO DE MERCADO
US$ 439,18 mi
PREÇO ABERTO
US$ 8,63
BAIXO (1 A)
US$ 2,24
ALTO (1 A)
US$ 12,34
BAIXO (24H)
US$ 8,59
ALTO (24H)
US$ 9,10
VOLUME (24H)
US$ 1,37 mi
87,67%
Histórico de preços
Time | Price | Change |
|---|---|---|
Hoje | US$ 8,63 | |
1 dia | US$ 8,61 | 0,00% |
1 semana | US$ 8,65 | |
1 mês | US$ 8,80 | |
1 ano | US$ 3,93 |